Re-evaluation of Mayo 2004 and revised Mayo 2012 staging in patients with AL amyloidosis in the era of new therapies

Foteini Theodorakakou; Despina Fotiou; Vasiliki Spiliopoulou; Magdalini Migkou; Panagiotis Malandrakis; Ioannis Ntanasis-Stathopoulos; Μαρία Ρούσσου; Nikolaos Kanellias; Evangelos Eleutherakis‐Papaiakovou; Eirini Solia; Asimina Papanikolaou; Charikleia Gakiopoulou; Julie Courraud; Panagiota Nikolaou; Stavroula Giannouli; Maria Gavriatopoulou; Evangelos Terpos; Meletios A Dimopoulos; Efstathios Kastritis

doi:10.1080/13506129.2025.2456790

Related publications

Article2023

Prognostic impact of translocation t(11;14) and of other cytogenetic abnormalities in patients with <scp>AL</scp> amyloidosis in the era of contemporary therapies

Despina Fotiou, Foteini Theodorakakou, Maria Gavriatopoulou, Magdalini Migkou, Panagiotis Malandrakis, Ioannis Ntanasis‐Stathopoulos, Nikolaos Kanellias, Evangelos Eleutherakis Papaiakovou, Evangelos Terpos, Asimina Papanikolaou, Charikleia Gakiopoulou, Meletios A Dimopoulos, Efstathios Kastritis

Article2015

Osteoprotegerin is a significant prognostic factor for overall survival in patients with primary systemic amyloidosis independent of the Mayo staging

Efstathios Kastritis, Maria Gavriatopoulou, Meletios A Dimopoulos, Evangelos Eleutherakis‐Papaiakovou, Nikolaos Kanellias, Μαρία Ρούσσου, Constandinos Pamboucas, Savvas Toumanidis, Evangelos Terpos

Article2015

Osteoprotegerin is a Significant Prognostic Factor for Overall Survival in Patients with Primary Systemic Amyloidosis Independent of the Mayo Staging

Efstathios Kastritis, M. Gavriatopoulos, Meletios A Dimopoulos, Evangelos Eleutherakis‐Papaiakovou, Nikolaos Kanellias, Μαρία Ρούσσου, Constandinos Pamboucas, Savvas Toumanidis, Evangelos Terpos

Article2011

European Collaborative Study of Treatment Outcomes in 347 Patients with Systemic AL Amyloidosis with Mayo Stage III Disease

Ashutosh Wechalekar, Stefan Schönland, Efstathios Kastritis, Philip N. Hawkins, Meletios A Dimopoulos, Paola Russo, Thirusha Lane, Andrea Foli, Darren Foard, Paolo Milani, Lisa Rannigan, Ute Hegenbart, Julian D. Gillmore, Giampaolo Merlini, Giovanni Palladini

Article2023

Incidence of Second Primary Malignancies in Patients with AL Amyloidosis and the Impact of Disease Stage and Therapies

Efstathios Kastritis, Vasiliki Spiliopoulou, Foteini Theodorakakou, Despina Fotiou, Evangelos Eleutherakis‐Papaiakovou, Magdalini Migkou, Μαρία Ρούσσου, Panagiotis Malandrakis, Ioannis Ntanasis‐Stathopoulos, Nikolaos Kanellias, Rodanthi Syrigou, Asimina Papanikolaou, Hariklia Gakiopoulou, Maria Gavriatopoulou, Evangelos Terpos, Meletios A Dimopoulos